Vakiener Victoria

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Vakiener Victoria's trades of Arrowhead Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
11.21
Quantity 817 -1.5%
Value US$9,159
US Epizyme Inc (EPZM)
Transaction date
Planned sale
Price
11.41
Quantity 599 -2.1%
Value US$6,835
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-19
PlS Planned sale
89,635 -22.0%
258.79
US$219,686 		89,635 -22.0% 258.79 US$219,686
2025-12-23 2025-12-19
PlS Planned sale
79,710 -34.4%
106.25
US$2,533,205 		79,710 -34.4% 106.25 US$2,533,205
2025-12-23 2025-12-19
PlS Planned sale
25,557 -45.4%
296.19
US$345,513 		25,557 -45.4% 296.19 US$345,513
2025-12-19 2025-12-19
PrS Proposed sale
10,040
67.68
US$679,464 		10,040 67.68 US$679,464
2024-12-18 2024-12-16
PlS Planned sale
8,994 -29.8%
21.91
US$197,059 		8,994 -29.8% 21.91 US$197,059
2024-12-16 2024-12-16
PrS Proposed sale
8,994
21.91
US$197,066 		8,994 21.91 US$197,066
2024-05-06 2024-05-02
PlS Planned sale
1,799 -5.6%
23.31
US$41,935 		1,799 -5.6% 23.31 US$41,935
2024-05-02 2024-05-02
PrS Proposed sale
1,799
23.29
US$41,904 		1,799 23.29 US$41,904
2024-01-16 2024-01-11
PlS Planned sale
1,100 -3.3%
38.84
US$42,724 		1,100 -3.3% 38.84 US$42,724
2024-01-16 2024-01-11
PlS Planned sale
3,620 -9.9%
37.87
US$137,089 		3,620 -9.9% 37.87 US$137,089
2024-01-11 2024-01-11
PrS Proposed sale
4,720
38.09
US$179,788 		4,720 38.09 US$179,788
2023-10-02 2023-09-28
S Sale
1,550 -6.7%
26.33
US$40,812 		1,550 -6.7% 26.33 US$40,812
2023-09-28 2023-09-28
PrS Proposed sale
1,550
26.30
US$40,765 		1,550 26.30 US$40,765
2021-02-05 2021-02-04
US Epizyme Inc (EPZM)
PlS Planned sale
817 -1.5%
11.21
US$9,159 		817 -1.5% 11.21 US$9,159
2021-01-27 2021-01-25
US Epizyme Inc (EPZM)
PlS Planned sale
599 -2.1%
11.41
US$6,835 		599 -2.1% 11.41 US$6,835